Umeclidinium 62.5 mcg/ACTUAT / vilanterol 25 mcg/ACTUAT Dry Powder Inhaler
RxNorm 1487525

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1487525 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: umeclidinium 62.5 mcg/ACTUAT / vilanterol 25 mcg/ACTUAT Dry Powder Inhaler.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Umeclidinium 0.0625 mg/ACTUAT / vilanterol 0.025 mg/ACTUAT Dry Powder Inhaler
Primary clinical definition
AUI:5940816
SY
Umeclidinium 62.5 mcg/ACTUAT / vilanterol 25 mcg/ACTUAT Dry Powder Inhaler
AUI:5948342

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCD

Semantic Clinical Drug (SCD):
Umeclidinium 0.0625 mg/ACTUAT / vilanterol 0.025 mg/ACTUAT Dry Powder Inhaler
(Atom ID: 5940816)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
E
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1487525
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
5940816
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
1487525
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXTERM FORM
DPI
The RxTerm dose form name for this drug

SY

Synonym (SY):
Umeclidinium 62.5 mcg/ACTUAT / vilanterol 25 mcg/ACTUAT Dry Powder Inhaler
(Atom ID: 5948342)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
E
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1487525
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
5948342
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1487525
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.